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In 2002, 13% of children aged between 2 and 14 years in South
Africa had lost a mother, a father or both parents.1 The Centre
for Actuarial Research at the University of the Western Cape
estimated that by July 2002 more than 885 000 children under
the age of 18 had lost their mothers, with 38% of those deaths
attributed to AIDS.2 Seen in the context of South Africa’s high
rate of mother-to-child HIV transmission, a great number of
orphaned children are likely to be living with HIV, having
contracted it through birth.  Although there is no research
examining the impact of HIV on the number of children who
have been abandoned, anecdotal evidence suggests that
children’s homes are seeing steep increases in the number of
children requiring care, many of whom are infected.
Children and ART
Both UNAIDS and the World Health Organisation (WHO)
recommend antiretroviral therapy (ART) for children with
HIV/AIDS, where clinically indicated.  The Southern African
HIV Clinicians Society gives the following rationale for the
administration of paediatric ART: ‘(i) restoration or
preservation of immunological function ...; (ii) improvement of
clinical symptoms; (iii) reduction of morbidity and mortality;
and (iv) maximal and durable suppression of viral load.
‘The overall objective of therapy is to enhance the quality
and quantity of life and to promote physical, social and
intellectual development of the child in the context of a
functional family.  A practical goal is to avoid hospitalisation
by minimising the impact of intercurrent disease ...’3
Where previously very few children were able to access ART
in South Africa and would not benefit from it as outlined
above, it is anticipated that with the roll-out of ART in the
public sector,4 substantially more children with HIV/AIDS
might be in a position to do so.  Yet it is important to note that
legal barriers exist preventing certain categories of vulnerable
children from accessing ART. One such group is children
without parents or legal guardians.
The legal position
South African common law requires that before medical
treatment, including HIV testing, can be administered to a
child, consent must be obtained from a parent or legal
guardian. The Child Care Act of 1983 regulates a number of
issues pertaining to children, and also requires the consent of a
parent or guardian to ‘any medical treatment’ administered to
a child under the age of 14 and ‘the performance of any
operation’ on a child under the age of 18.5 (It should be noted
that the Choice of Termination of Pregnancy Act of 1996
provides that young women of any age may seek and obtain
termination of pregnancy without the consent of their parents.
The Act makes provision for counselling and includes a
recommendation that parental consent be sought, but this is
not mandatory.) HIV testing, the provision of ART and post-
exposure prophylaxis (PEP) for child survivors of rape are
considered to be ‘medical treatment’ and therefore necessitate
the consent of a parent or guardian for children under the age
of 14.  In the absence of parental consent, the Minister of Social
Development may be approached to give consent and in
urgent cases the medical superintendent of a hospital may give
consent for medical treatment for children aged under 14 years.
The High Court is the upper guardian of all children and may
also be approached for consent.
Increase in informal caregivers
The increase of AIDS mortality rates, the impact of HIV on
families and the rise in the number of orphans in South Africa
has created a situation in which a growing number of children
are cared for informally by grandparents, aunts, uncles,
siblings or sympathetic members of the community. Many
caregivers are unaware of the need to formalise the care
relationship and those who do attempt to foster or adopt
children in their care face a lengthy process administered by an
increasingly overstretched system.  
Caregivers who have not formalised their relationship with
the children they care for are not recognised in law as the legal
guardians of orphaned or abandoned children, and therefore
cannot give the consent needed for the medical treatment of
these children.
In the context of ART this would give rise to the unfortunate
state of affairs in which health workers, in keeping with the
provisions of the Act and common law, would have to apply to
the Minister of Social Development or the High Court for
special permission to administer this treatment.  With an
increasing number of children being orphaned and abandoned
by parents with HIV/AIDS, and in time requiring ART if they
have contracted the virus, it is clear that the current legal
arrangement creates an intolerable situation.
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AIDS Law Project cases
The experience of the AIDS Law Project (ALP) might be
informative in this regard.  The ALP provides legal advice and
assistance to the University of the Witwatersrand (Wits)
Paediatric HIV Working Group, a group of paediatricians and
other health workers who provide treatment and care to
children and their families in the public sector.
In May 2003, the Harriet Shezi Clinic, which forms part of
the Wits Paediatric HIV Working Group, secured private
funding to provide ART to 10 children with HIV/AIDS
attending the clinic.  In 2003, ART was not available in the
public health system and provision of this therapy was
designed as  part of a research study intended to: (i) evaluate
the administration of ART to children attending urban public
hospitals; (ii) build capacity in state hospitals for the
administration of antiretroviral medicines to children and their
families by developing a model treatment clinic where public
sector staff can be trained in effective management of
paediatric HIV; and (iii) assess the feasibility of, and identify
what the obstacles are in administering antiretroviral medicines
in a resource-poor setting.6
Four of the children who were selected to receive the
treatment had no parents or guardians and were being looked
after by relatives or friends.  The ALP brought an urgent
application on behalf of the four children in the Johannesburg
High Court, requesting the court to grant permission for the
children to commence treatment.  The order granted by the
court authorised Dr Meyers of the Wits Paediatric HIV
Working Group to provide the children with treatment in
accordance with the protocol laid out in ‘Antiretroviral
Therapy in Children, Southern African HIV Clinicians Society
Guidelines’3 and the WHO’s Scaling Up Anti-retroviral Therapy in
Resource-limited Settings: Guidelines for a Public Health Approach.7
The High Court granted this order on 10 June 2003 and the
children started ART immediately.  A similar order was granted
for another child on 19 August 2003.8
Although both court applications were successful, it was
clear that it would not be feasible to approach the court on
behalf of each child requiring HIV testing or treatment who
was without a legal guardian. The announcement on 8 August
2003 that the Cabinet approved the roll-out of ARVs in the
public sector created an urgent need for effective and efficient
mechanisms to be put in place to ensure that these children
would be able to access treatment when it became available.
Section 39 of the Child Care Act of 1983 makes provision for
consent to be obtained from the Minister of Social
Development, in the absence of parental consent.  Although the
provision at least theoretically provides a speedy and
inexpensive mechanism to obtain consent, few organisations
and individuals have been able to use it.
On  31 October 2003 the ALP wrote to the Minister of Social
Development on behalf of a number of doctors from the Wits
Paediatric Working Group, requesting authorisation from the
Minister to provide medical treatment (in particular access to
ART) to five orphaned children with HIV/AIDS.  On 3
November the Minister provided his consent, and the ALP
then requested authorisation for a further 40 children in similar
positions attending the Harriet Shezi Clinic, Coronation
Hospital or living in children’s homes.  Despite repeated
requests, no further response was received from the Minister.
It was clear that the provisions of Section 39 would not
alleviate the problems relating to consent.
Subsequently, a third urgent application was lodged at the
High Court, requesting the court to: 
1. Provide consent to the Wits Paediatric Working Group to
test and treat eight children for HIV as they did not have
parents or legal guardians to provide such consent;
2. Provide consent to the Wits Paediatric Working Group to
test and treat for HIV any child under 14 who did not have a
parent or guardian or whose parent or guardian could not
readily be located, provided that: (i) a medical practitioner
registered under the Health Professions Act 56 of 1974, certified
in writing that in his or her professional judgment, the test or
treatment was in the child’s best interests; and (ii) if the child
was in the daily care of an adult, the latter consented to the test
or treatment.
On 5 December 2003 the High Court granted this order,
thereby allowing the Wits Paediatric Working Group to
provide ART and HIV testing to orphaned and abandoned
children with HIV/AIDS in their care, without any legal
impediments.9
Legal impasse 
It should be noted that this court order only applies to the Wits
Paediatric Working Group and cannot be used by other
medical practitioners dealing with children in similar
situations.  It would seem that unless the Departments of Social
Development and Health take urgent action, this legal
predicament will continue until the new Children’s Bill
replaces the old Child Care Act.  The latest draft of the
Children’s Bill gives caregivers or any persons who
‘voluntarily care for the child either indefinitely, temporarily or
partially’ the right to ‘consent to any medical examination or
treatment of the child if such consent cannot reasonably be
obtained from the parent or primary care-giver of the child’.10
The Bill also lowers the age at which children can consent to
medical treatment to 12 years — provided that the child is of
sufficient maturity and has satisfactory mental capacity to
make sound decisions.11 
Although these provisions will substantially alleviate the
problems in obtaining consent, it is not clear when the Bill will
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be passed into law.  Although the Department of Social
Development indicated that it enjoys a high level of priority,
there is no indication when it will become law.  In the interim
period, many children are left in a vulnerable and
unnecessarily tenuous position.
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A novel and effective treatment for pruritus ani
IN BRIEF
Pruritus ani is a common proctological problem, characterised by intense itching localised in the anus and perianal skin. It
may result from an underlying disorder of the epithelium in that area, or from anorectal pathology. In many cases it is not
possible to determine the cause. Faecal contamination of the perineum in the absence of gross soiling, irritant chemicals in
faeces, allergies to locally applied agents or components of the diet, and even psychosomatic factors have been suggested as
possible causes but are not conclusively proved to be of relevance.
Capsaicin is a natural alkaloid derived from plants of the Solanaceae family, and topical capsaicin is known to be effective and
safe in the treatment of pain and itching.
A double blind placebo-controlled study of capsaicin in the treatment of chronic idiopathic pruritus ani was reported
recently in the journal Gut (2003; 52:1323-1326).
After an open pilot study on 5 patients, a double-blind, placebo-controlled crossover study was conducted on 44 patients.
The patients were randomised to receive either capsaicin (0.006%) or a menthol placebo (1%) for 4 weeks. After a washout
period of 1 week, the placebo group was given capsaicin and the capsaicin group received placebo.
Results: 31 of 44 patients experienced relief during capsaicin treatment and did not respond to menthol. During the follow-
up period of a mean of 10.9 months, the 'responders' required an application of capsaicin every day to remain symptom-free.
The investigators concluded that capsaicin is a new, safe, and highly effective treatment for severe intractable pruritus ani.
